The Effects of Passive Vibration in Patients With Diabetic Peripheral Neuropathy
Study Details
Study Description
Brief Summary
The purpose of this study is to examine the effects of passive vibration (PV) in improving balance and sensation in patients with diabetic peripheral neuropathy (DPN).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The study involves the following:
-
Visit 1:
-
Particpant's age, height, gender, and weight will be collected.
-
Participant will fill out a questionnaire to assess participant's nerve function. This process will take approximately 2.5 minutes.
-
Investigator will measure participant's balance, sensation, and skin blood flow (SBF).
-
After completing the tests, participant will be randomly assigned by the computer to either the treatment group or control group.
-
The treatment group will receive a passive vibration treatment for 15 minutes twice a week for 4 weeks.
-
The control group will not receive any treatment and they will continue their usual lifestyle.
-
Visit 2 through 8:
-
The treatment group will receive a passive vibration for 15 minutes followed by SBF measurement.
-
The control group will continue their usual lifestyle.
-
In the fifth session, the treatment and control groups will come back for tests.
-
Visit 9 (follow-up):
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: passive vibration group The passive vibration group patients will receive passive vibration (50 Hz, one cycle= 60 seconds working time with 2 seconds rest time) on their calf in supine position for ten minutes. The total number of sessions will be nine. Passive vibration will be given to the treatment group twice a week for four weeks (eight sessions) and the ninth session will be the follow up. At every session, the skin blood flow will be measured before, immediately, and 15 minutes after passive vibration. |
Other: passive vibration
The passive vibration is delivered using a Physio Plate (Domino S.R.L, San Vendemiano, Italy). The frequency delivered is 50 Hz for a total number of ten cycles for a period of ten minutes approximately (one cycle= 60seconds working time with 2 seconds rest time).
|
| Active Comparator: no passive vibration group The control group will not receive any treatment and continue their usual lifestyle. Balance, sensory measurement and skin blood flow will be taken at the beginning of the study, prior to the 5th treatment, and 1 week after the last intervention . |
Other: no passive vibration
The control group will not receive any treatment and continue their usual lifestyle.
|
Outcome Measures
Primary Outcome Measures
- Skin blood flow [Change between Baseline and Week Nine Visit]
Patient will be positioned in prone on a plinth as their skin is marked for blood flow assessment. A 3 cm x 3 cm square shape will be marked on the posterior aspect of the calf (muscle belly) and on the plantar aspect of the first three metatarsal heads. MOOR Full-field Laser Perfusion Image(FLPI) (MOOR FLPI V 2.1, Oxford, England) will be used for measurement of skin blood flow in a patient with DPN, which will be pre-warmed for about 30 minutes. The perpendicular red light laser beam will be used to capture SBF and blood flow is measured in '"Flux" unit.
Secondary Outcome Measures
- balance [at each of the nine visits( 90 minutes each visit: twice per week)]
The NeuroCom Smart Balance Master System Computerized dynamic posturography (CDP) will be used in this research to measure balance. The platform consists of two force plates that can be modulated in the up-down and anterior-posterior direction. The sensory organization test (SOT) will be used to measure balance. The result of CDP determines any anomalies in visual, somatosensory and vestibular systems that control posture.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
A diagnosis of Diabetic Peripheral Neuropathy
-
Minimum age 40 years
-
Maximum Age 75 years
-
Ability to stand for a minimum of five minutes
Exclusion Criteria:
-
Neurological Disorders
-
Bleeding Disorders
-
Leg Ulcers
-
Cardiovascular Diseases
-
Complete absence of sensation in lower extremities (i.e. 6.65 in monofilament test)
-
Self-reported pregnancy
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Loma Linda University | Loma Linda | California | United States | 92350 |
Sponsors and Collaborators
- Loma Linda University
Investigators
- Principal Investigator: Everett Lohman, DSc, Loma Linda University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 5170453